ZNF605
gene geneOn this page
Summary
ZNF605 (zinc finger protein 605, HGNC:28068) is a protein-coding gene on chromosome 12q24.33, encoding Zinc finger protein 605 (Q86T29). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 100289635 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_183238
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28068 |
| Approved symbol | ZNF605 |
| Name | zinc finger protein 605 |
| Location | 12q24.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196458 |
| Ensembl biotype | protein_coding |
| Entrez | 100289635 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 13 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000331711, ENST00000360187, ENST00000381215, ENST00000392321, ENST00000412621, ENST00000539809, ENST00000891951, ENST00000891952, ENST00000891953, ENST00000891954, ENST00000891955, ENST00000920344, ENST00000920345, ENST00000920346, ENST00000957903, ENST00000957904, ENST00000957906
RefSeq mRNA: 2 — MANE Select: NM_183238
NM_001164715, NM_183238
CCDS: CCDS31938, CCDS53850
Canonical transcript exons
ENST00000360187 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001470908 | 132948148 | 132948270 |
| ENSE00001470909 | 132956243 | 132956306 |
| ENSE00002305965 | 132918306 | 132927162 |
| ENSE00003493595 | 132933035 | 132933155 |
| ENSE00003530841 | 132945621 | 132945797 |
Expression profiles
Bgee: expression breadth ubiquitous, 196 present calls, max score 86.49.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.6588 / max 110.6103, expressed in 1679 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 134262 | 6.6588 | 1679 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 86.49 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.24 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.61 | gold quality |
| tibia | UBERON:0000979 | 83.44 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.29 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.82 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.65 | gold quality |
| cerebellum | UBERON:0002037 | 81.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.83 | gold quality |
| apex of heart | UBERON:0002098 | 81.59 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.08 | gold quality |
| thyroid gland | UBERON:0002046 | 81.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.86 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.60 | gold quality |
| right uterine tube | UBERON:0001302 | 80.46 | gold quality |
| adenohypophysis | UBERON:0002196 | 80.22 | gold quality |
| lower esophagus | UBERON:0013473 | 80.07 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 80.07 | gold quality |
| right ovary | UBERON:0002118 | 79.97 | gold quality |
| fallopian tube | UBERON:0003889 | 79.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.91 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.85 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 79.75 | gold quality |
| left ovary | UBERON:0002119 | 79.59 | gold quality |
| pituitary gland | UBERON:0000007 | 79.35 | gold quality |
| body of uterus | UBERON:0009853 | 79.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 79.00 | gold quality |
| ventricular zone | UBERON:0003053 | 78.89 | gold quality |
| right adrenal gland | UBERON:0001233 | 78.82 | gold quality |
| right lobe of liver | UBERON:0001114 | 78.81 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8142 | yes | 16.82 |
| E-GEOD-137537 | yes | 5.75 |
| E-ANND-3 | yes | 5.15 |
| E-MTAB-6379 | no | 253.77 |
| E-MTAB-7303 | no | 107.57 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
126 targeting ZNF605, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp605 | ENSMUSG00000023284 |
| rattus_norvegicus | Zfp605 | ENSRNOG00000037428 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 605 — Q86T29 (reviewed: Q86T29)
All UniProt accessions (1): Q86T29
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86T29-1 | 1 | yes |
| Q86T29-2 | 2 |
RefSeq proteins (2): NP_001158187, NP_899061* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (23 total): zinc finger region 17, cross-link 2, chain 1, domain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86T29-F1 | 74.05 | 0.22 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 77, 391
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 53 (showing top):
CHANDRAN_METASTASIS_UP, chr12q24, CHANDRAN_METASTASIS_TOP50_UP, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, ROESSLER_LIVER_CANCER_METASTASIS_DN, CBX5_TARGET_GENES, E2F5_TARGET_GENES, ZNF197_TARGET_GENES, ZNF22_TARGET_GENES, ZNF350_TARGET_GENES, ZNF711_TARGET_GENES, ZNF766_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR579_3P, MIR664B_3P
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
438 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF605 | ARMCX4 | Q5H9R4 | 507 |
| ZNF605 | YJEFN3 | A6XGL0 | 448 |
| ZNF605 | SLF2 | Q8IX21 | 441 |
| ZNF605 | M9MMK7 | M9MMK7 | 432 |
| ZNF605 | NOAZFP | Q9Y3S2 | 418 |
| ZNF605 | PCMTD1 | Q96MG8 | 417 |
| ZNF605 | LINC02881 | B7Z368 | 406 |
| ZNF605 | MOCOS | Q96EN8 | 398 |
| ZNF605 | IGSF10 | Q6WRI0 | 397 |
| ZNF605 | PCDHGB4 | Q9UN71 | 380 |
| ZNF605 | NUDT5 | Q9UKK9 | 378 |
| ZNF605 | TMEM178B | H3BS89 | 372 |
| ZNF605 | YIPF4 | Q9BSR8 | 369 |
| ZNF605 | CMYA5 | Q8N3K9 | 367 |
| ZNF605 | AFG2B | Q9BVQ7 | 357 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APP | ZNF605 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): ZNF605 (Two-hybrid), ZNF605 (Two-hybrid)
ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, A8MUV8, B4DXR9, C9JN71, O75346, O75373, O95780, P0CJ79, P0DKX0, P0DPD5, P17019, P17035, P35789, Q03923, Q03938, Q08AN1, Q14593, Q15928, Q3SXZ3, Q3ZCX4, Q5MCW4, Q5R9S5, Q5RER9, Q68DY1, Q6JLC9, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q76KX8, Q86T29, Q86V71, Q8IYN0, Q8N4W9, Q8N7M2, Q8NEM1, Q8TD23
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1180 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:132933029:TCTTA:T | donor_loss | 1.0000 |
| 12:132933030:CTTA:C | donor_loss | 1.0000 |
| 12:132933031:TTA:T | donor_loss | 1.0000 |
| 12:132933032:T:TG | donor_loss | 1.0000 |
| 12:132933033:A:AC | donor_gain | 1.0000 |
| 12:132933033:A:AG | donor_loss | 1.0000 |
| 12:132933033:AC:A | donor_gain | 1.0000 |
| 12:132933034:C:CC | donor_gain | 1.0000 |
| 12:132933034:CC:C | donor_gain | 1.0000 |
| 12:132948147:CA:C | donor_gain | 1.0000 |
| 12:132956241:ACC:A | donor_gain | 1.0000 |
| 12:132956242:CCC:C | donor_gain | 1.0000 |
| 12:132928335:AAAT:A | donor_gain | 0.9900 |
| 12:132928336:A:C | donor_gain | 0.9900 |
| 12:132928376:T:TA | donor_gain | 0.9900 |
| 12:132936523:T:C | acceptor_gain | 0.9900 |
| 12:132936525:G:C | acceptor_gain | 0.9900 |
| 12:132948125:T:TA | donor_gain | 0.9900 |
| 12:132956062:T:TA | donor_gain | 0.9900 |
| 12:132933153:TAT:T | acceptor_gain | 0.9800 |
| 12:132933153:TATC:T | acceptor_loss | 0.9800 |
| 12:132933154:ATC:A | acceptor_loss | 0.9800 |
| 12:132933155:TC:T | acceptor_loss | 0.9800 |
| 12:132933157:T:G | acceptor_loss | 0.9800 |
| 12:132933159:GAAAA:G | acceptor_loss | 0.9800 |
| 12:132936523:T:TC | acceptor_gain | 0.9800 |
| 12:132948147:CACT:C | donor_gain | 0.9800 |
| 12:132948187:G:C | donor_gain | 0.9800 |
| 12:132956236:C:CA | donor_gain | 0.9800 |
| 12:132956237:CCTTA:C | donor_loss | 0.9800 |
AlphaMissense
4300 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:132925757:A:C | F514L | 0.997 |
| 12:132925757:A:T | F514L | 0.997 |
| 12:132925759:A:G | F514L | 0.997 |
| 12:132925673:A:C | F542L | 0.996 |
| 12:132925673:A:T | F542L | 0.996 |
| 12:132925675:A:G | F542L | 0.996 |
| 12:132926513:G:C | F262L | 0.996 |
| 12:132926513:G:T | F262L | 0.996 |
| 12:132926515:A:G | F262L | 0.996 |
| 12:132926597:A:C | F234L | 0.996 |
| 12:132926597:A:T | F234L | 0.996 |
| 12:132926599:A:G | F234L | 0.996 |
| 12:132926681:A:C | F206L | 0.996 |
| 12:132926681:A:T | F206L | 0.996 |
| 12:132926683:A:G | F206L | 0.996 |
| 12:132926261:G:C | F346L | 0.995 |
| 12:132926261:G:T | F346L | 0.995 |
| 12:132926263:A:G | F346L | 0.995 |
| 12:132925505:G:C | F598L | 0.994 |
| 12:132925505:G:T | F598L | 0.994 |
| 12:132925507:A:G | F598L | 0.994 |
| 12:132925841:G:C | F486L | 0.994 |
| 12:132925841:G:T | F486L | 0.994 |
| 12:132925843:A:G | F486L | 0.994 |
| 12:132925925:G:C | F458L | 0.994 |
| 12:132925925:G:T | F458L | 0.994 |
| 12:132925927:A:G | F458L | 0.994 |
| 12:132926160:A:G | L380P | 0.994 |
| 12:132926429:G:C | F290L | 0.994 |
| 12:132926429:G:T | F290L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000018757 (12:132934567 G>A), RS1000070213 (12:132952185 G>A,C), RS1000173422 (12:132954221 C>T), RS1000266719 (12:132954119 T>C), RS1000447676 (12:132950294 A>C), RS1000533272 (12:132929885 T>C), RS1000756595 (12:132923145 G>A), RS1000882103 (12:132950455 G>A,T), RS1000898926 (12:132946435 C>G,T), RS1000929610 (12:132946631 A>T), RS1000966164 (12:132930158 G>C), RS1001089019 (12:132941228 A>G), RS1001213753 (12:132944290 C>A,T), RS1001290106 (12:132949923 T>C), RS1001291130 (12:132940957 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_179 | Refractive error | 1.000000e-12 |
| GCST90002390_182 | Mean corpuscular hemoglobin | 6.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation, increases methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| avobenzone | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Succimer | increases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Nicotine | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Magnetite Nanoparticles | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.